---
title: "Integra LifeSciences (IART.US) — Financial Reports"
type: "Symbol"
locale: "en"
url: "https://longbridge.com/en/quote/IART.US/norm.md"
symbol: "IART.US"
name: "Integra LifeSciences"
parent: "https://longbridge.com/en/quote/IART.US.md"
datetime: "2026-03-18T11:39:40.414Z"
locales:
  - [en](https://longbridge.com/en/quote/IART.US/norm.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/IART.US/norm.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/IART.US/norm.md)
---

> Supported Languages: [简体中文](https://longbridge.com/zh-CN/quote/IART.US/norm.md) | [繁體中文](https://longbridge.com/zh-HK/quote/IART.US/norm.md)


# Integra LifeSciences (IART.US) — Financial Reports

## Income Statement (USD)

| Indicator | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 |
| --- | --- | --- | --- | --- | --- |
| EPS | -0.0230 | -0.0704 | -6.31 | -0.3308 | 0.2528 |
| ROE | -0.65% | -2.08% | -151.11% | -6.59% | 5.07% |
| Revenue | 434.93M | 402.06M | 415.61M | 382.65M | 442.65M |
| Net income | -1.70M | -5.40M | -484.07M | -25.29M | 19.43M |
| Operating income | 54.10M | 39.89M | 32.67M | 31.48M | 68.92M |
| Gross margin | 56.36% | 57.16% | 55.15% | 56.23% | 61.10% |
| Net margin | -0.39% | -1.34% | -116.47% | -6.61% | 4.39% |
| Profit quality | 457.89% | 97.52% | 366.34% | -279.64% | 135.83% |

## Balance Sheet (USD)

| Indicator | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 |
| --- | --- | --- | --- | --- | --- |
| A&L | 3.60B | 3.65B | 3.67B | 4.05B | 4.04B |
| Leverage | 3.45 | 3.51 | 3.53 | 2.66 | 2.61 |
| BVPS | 13.40 | 13.33 | 13.33 | 19.61 | 20.03 |
| Turnover | 0.4281 | 0.4261 | 0.4189 | 0.3995 | 0.4119 |
| Cash & STI | 263.74M | 267.88M | 253.61M | 273.30M | 273.57M |
| Inv & Rec | 492.74M | 489.11M | 465.13M | 445.42M | 429.09M |
| LT assets | 584.90M | 575.55M | 571.39M | 561.38M | 549.76M |
| Net debt | 1.77B | 1.74B | 1.76B | 1.75B | 1.71B |

## Cash Flow Statement (USD)

| Indicator | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 |
| --- | --- | --- | --- | --- | --- |
| Operating CF | 11.82M | 40.91M | 8.92M | -11.26M | 50.74M |
| Investing CF | -34.91M | -15.59M | -21.65M | -35.92M | -4.25M |
| Financing CF | 24.34M | -10.24M | -21.14M | 35.38M | -7.15M |
| Free CF | 30.54M | 71.07M | -6.92M | -5.16M | 73.24M |
| OCF coverage | 27.93% | 6.51% | 24.75% | -25.49% | 72.96% |
| Repaid & issued | 49.70M | 603.70M | 12.90M | 54.40M | 35.40M |
| CapEx | -17.21M | -15.16M | -20.15M | -28.92M | -29.60M |